Fumagillin for intestinal microsporidiosis.
Carr
Andrew
A
Cooper
David A
DA
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003510:Cyclohexanes; D021862:Enterocytozoon; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D016881:Microsporidiosis / Q000188:drug therapy*; D012717:Sesquiterpenes
D019380:Anti-HIV Agents; D000981:Antiprotozoal Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; C026211:fumagillin